Comparison of suppressive hormonal therapy(LD tablet) with aspiration in regression of ovarian endometrioma
Phase 2
Recruiting
- Conditions
- Endometriosis of ovary.Endometriosis of ovary
- Registration Number
- IRCT201609105563N8
- Lead Sponsor
- Vice chancellor for Research,Tabriz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
womens aged 15-45; unilateral endometrioma, endometrioma diagnosis with ultrasound; CA 125<100; mass size less than or equal to 6 cm
Exclusion criteria:
the possibility of malignancy; contraindications of LD pill; ischemic heart disease or previous history of it; current breast cancer; liver tumors (benign and malignant))
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Size of the cyst. Timepoint: One, three and six months after treatment. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method Dysmenorrhea. Timepoint: One, three and six months after treatment. Method of measurement: Questionnaire.;Dyspareunia. Timepoint: One, three and six months after treatment. Method of measurement: Questionnaire.;Pelvic pain. Timepoint: One, three and six months after treatment. Method of measurement: (Incontinence quality of life =I-QOL).